Cutaneous Allodynia as a Prognostic Factor in the Treatment of Migraine with Botulinum Toxin

被引：0
|
作者：
Mathew, P. [1 ]
Cutrer, F. M. [1 ]
Garza, I. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
HEADACHE | 2010年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S32 / S33
页数：2
相关论文
共 50 条
  • [11] Botulinum A toxin for treatment of chronic migraine
    Grazzi, L.
    Usai, S.
    Bussone, G.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [12] Botulinum Toxin A for Treatment of Chronic Migraine
    Grazzi, L.
    Usai, S.
    Bussone, G.
    CEPHALALGIA, 2013, 33 (S8) : 67 - 68
  • [13] Is there a role for botulinum toxin in the treatment of migraine?
    Stefan Evers
    Current Pain and Headache Reports, 2003, 7 (3) : 229 - 234
  • [14] Cutaneous allodynia in migraine
    不详
    NEUROSCIENTIST, 2008, 14 (03): : 234 - 234
  • [15] Cutaneous allodynia as predictor for treatment response in chronic migraine
    Pijpers, Judith A.
    Kies, Dennis A.
    van Zwet, Erik W.
    de Boer, Irene
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 122 - 122
  • [16] Central sensitisation and cutaneous allodynia in migraine - Implications for treatment
    Landy, S
    Rice, K
    Lobo, B
    CNS DRUGS, 2004, 18 (06) : 337 - 342
  • [17] Botulinum toxin type A for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial
    Hollanda, Luciano
    Monteiro, Larissa
    Melo, Ailton
    NEUROLOGY INTERNATIONAL, 2014, 6 (04) : 70 - 73
  • [18] Botulinum toxin - A treatment for migraine? A systematic review
    Gupta, Vinod Kumar
    PAIN MEDICINE, 2006, 7 (05) : 386 - 394
  • [19] Botulinum toxin type A (BOTOX) for treatment of migraine
    Binder, WJ
    Brin, MF
    Blitzer, A
    Pogoda, JM
    DM DISEASE-A-MONTH, 2002, 48 (05): : 323 - 335
  • [20] Botulinum toxin type A as a migraine preventive treatment
    Silberstein, S
    Mathew, N
    Saper, J
    Jenkins, S
    HEADACHE, 2000, 40 (06): : 445 - 450
12345